Mitral valve replacement is commonly performed in Israel. It is indicated in cases of abnormal changes (i.e. mitral regurgitation or mitral valve prolapse) to the valve’s leaflets due to conditions such as rheumocarditis, calcinosis or fibrosis, or formation of adhesions. The goal of the treatment is to replace the damaged valve with either a mechanical (metal) or bioprosthesis made from animal tissue.
While mechanical mitral valves generally last longer, they require taking blood thinners on a permanent basis. Using a bioprosthesis reduces the risk of developing thrombosis and inflammations so no additional medicinal treatment is needed; however, it normally only lasts for about 10 to 15 years before having to be replaced again. The decision regarding the type of valve to be used will be taken by your treating specialists.
The diagnostics program will take 2 business days to complete. All tests will take place at the state-of-the-art [[Assuta Medical Center]] in Tel Aviv.
If surgical intervention is indicated, the cost of the procedure will include the following:
Please note that mitral valve replacement can be performed either as open heart surgery or endoscopically (minimally invasive procedure). The later involves a shorter recovery time with less pain and a reduced risk of developing infection. However, as not all people are able to undergo this procedure, the decision regarding the type of procedure will be taken by your treating physicians.
Please note that if you are suffering from IHD (ischemic heart disease) symptoms (or signs of the condition are noted during the ECG) it is possible to combine mitral valve replacement with a coronary bypass (CABG).